User Reviews for Acalabrutinib
Brand names: Calquence
Acalabrutinib has an average rating of 7.3 out of 10 from a total of 3 ratings on Drugs.com. 67% of reviewers reported a positive experience, while 33% reported a negative experience.
|Chronic Lymphocytic Leukemia||2 reviews||23 medications|
|Mantle Cell Lymphoma||1 reviews||9 medications|
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published.
Calquence (acalabrutinib) for Chronic Lymphocytic Leukemia "Have had CLL for 10 years. Joined early MDAnderson ACP196 trial for previously untreated 6 years ago, after having great build up of fluid around lungs. All problems went away within a couple of months after starting treatment. Life is normal with no side effects. Have traveled the world since. Still a trial participant."
For Chronic Lymphocytic Leukemia "Diagnosed CLL 7 months now August 2021. WBC was 453 . Two weeks after starting treatment Calquence acalbrutinib my WBC dropped to almost half 226. To date I am below 10. Very happy with results. My only side effect from medication long time exposure to direct sun causes headache and could cause skin problems. Told to use sunblock. It is working for me. Pill 100mg 2x day."
For Mantle Cell Lymphoma "Remission after Retuxen and Bendeka was only about 4-5 months at best so this was next after one failure. 1st month was fine- few side effects and obvious symptoms decreased but by the end of month 3 my symptoms returned. Side effects became distressing- GERD with fatty sensations, nightly abdominal pain … so disappointing. It seems odd for a mere patient to review a drug since medicine is hardly straight forward."
Frequently asked questions
This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about acalabrutinib
- Check interactions
- Side effects
- Dosage information
- During pregnancy
- Drug class: BTK inhibitors
- En español